Virus roundup …  

    • Johnson & Johnson launched a 60,000-person clinical trial of its single-dose COVID-19 vaccine on three continents, becoming the fourth experimental shot to enter final-stage testing in the U.…


    Already a subscriber? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.